Vascular Function and the Role of Oxidative Stress in Heart Failure, Heart Transplant, and Beyond

被引:32
作者
Witman, Melissa A. H. [1 ,2 ]
Fjeldstad, Anette S. [3 ]
McDaniel, John [1 ,4 ]
Ives, Stephen J. [1 ,2 ]
Zhao, Jia [5 ]
Barrett-O'Keefe, Zachary [1 ,2 ]
Nativi, Jose N. [6 ]
Stehlik, Josef [6 ]
Wray, D. Walter [1 ,2 ,5 ]
Richardson, Russell S. [1 ,2 ,5 ]
机构
[1] George E Whalen VA Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA
[2] Univ Utah, Dept Exercise & Sport Sci, Salt Lake City, UT USA
[3] Univ Utah, Dept Neurol, Salt Lake City, UT USA
[4] Kent State Univ, Dept Exercise Sci, Kent, OH 44242 USA
[5] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA
[6] George E Whalen VA Med Ctr, Dept Internal Med, Div Cardiol, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
antioxidants; flow-mediated vasodilation; vascular health; blood flow; ENDOTHELIUM-DEPENDENT VASODILATION; CHRONIC MYOCARDIAL-INFARCTION; FLOW-MEDIATED DILATION; NITRIC-OXIDE; VITAMIN-C; INDEPENDENT VASODILATION; CARDIAC TRANSPLANTATION; PERIPHERAL VASCULATURE; SUPEROXIDE-DISMUTASE; RELAXING FACTOR;
D O I
10.1161/HYPERTENSIONAHA.112.193318
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Using flow-mediated vasodilation (FMD), reactive hyperemia, and an acute oral antioxidant cocktail (AOC; vitamins C and E and alpha-lipoic acid), this study aimed to provide greater insight into altered vascular function and the role of oxidative stress in chronic heart failure patients with reduced ejection fraction (HFrEF) and at several time points beyond heart transplantation (HTx). A total of 61 age-matched subjects (12 healthy controls, 14 New York Heart Association class II and III HFrEF, and 35 HTx recipients [<3 years post-HTx, 5-10 years post-HTx, and >14 years post-HTx]) ingested either placebo (PL) or an AOC before FMD and reactive hyperemia testing of the brachial artery. Vascular function, as measured by FMD, was not different among the controls (6.8 +/- 1.9%), recent <3-year post-HTx group (8.1 +/- 1.2%), and the 5- to 10-year post-HTx group (5.5 +/- 1.0%). However, PL FMD was lower in the HFrEF (4.5 +/- 0.7%) and in the >14-year post-HTx group (2.9 +/- 0.8%). The AOC increased plasma ascorbate levels in all of the groups but only increased FMD in the controls (PL, 6.8 +/- 1.9%; AOC, 9.2 +/- 1.0%) and >14-year post-HTx recipients (PL, 2.9 +/- 0.8%; AOC, 4.5 +/- 1.3%). There were no differences in reactive hyperemia in any of the groups with PL or AOC. This cross-sectional study reveals that, compared with controls, vascular function is blunted in HFrEF, is similar soon after HTx, but is decreased with greater time post-HTx with free radicals implicated in this progression. (Hypertension. 2012; 60: 659-668.)
引用
收藏
页码:659 / 668
页数:10
相关论文
共 55 条
  • [51] INCREASED NITRIC-OXIDE PRODUCTION IN HEART-FAILURE
    WINLAW, DS
    SMYTHE, GA
    KEOGH, AM
    SCHYVENS, CG
    SPRATT, PM
    MACDONALD, PS
    [J]. LANCET, 1994, 344 (8919) : 373 - 374
  • [52] Acute Reversal of Endothelial Dysfunction in the Elderly After Antioxidant Consumption
    Wray, D. Walter
    Nishiyama, Steven K.
    Harris, Ryan A.
    Zhao, Jia
    McDaniel, John
    Fjeldstad, Anette S.
    Witman, Melissa A. H.
    Ives, Stephen J.
    Barrett-O'Keefe, Zachary
    Richardson, Russell S.
    [J]. HYPERTENSION, 2012, 59 (04) : 818 - 824
  • [53] Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome
    Wray, D. Walter
    Uberoi, Abhimanyu
    Lawrenson, Lesley
    Bailey, Damian M.
    Richardson, Russell S.
    [J]. CLINICAL SCIENCE, 2009, 116 (5-6) : 433 - 441
  • [54] SIMPLE FLUOROMETRIC ASSAY FOR LIPOPEROXIDE IN BLOOD-PLASMA
    YAGI, K
    [J]. BIOCHEMICAL MEDICINE, 1976, 15 (02): : 212 - 216
  • [55] ZOJA C, 1986, LAB INVEST, V55, P455